Symbols / AKRO
AKRO Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-02-27 16:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- $AKRO stock is up 16% today. Here's what we see in our data. - Quiver Quantitative hu, 09 Oct 2025 07
- Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring a 20% Upside Potential in Biotech - DirectorsTalk Interviews Mon, 13 Oct 2025 07
- Akero Therapeutics (AKRO): Examining Valuation After Strong Year-to-Date Share Price Gains - Yahoo Finance Mon, 10 Nov 2025 08
- Evaluating Akero Therapeutics (AKRO): Is the Current Valuation Justified After Recent Share Price Momentum? - simplywall.st Sat, 08 Nov 2025 08
- Biggest stock movers Thursday: TLRY, AKRO, DAL, RACE, and more - Seeking Alpha hu, 09 Oct 2025 07
- Up to $5.2B deal: Novo Nordisk to acquire Akero Therapeutics; shareholders to receive $54 per share - Stock Titan hu, 09 Oct 2025 07
- What is the target price for AKRO stock - July 2025 Earnings & Detailed Earnings Play Alerts - mfd.ru Fri, 20 Feb 2026 22
- Why Akero Therapeutics Stock Trounced the Market on Thursday - The Motley Fool hu, 09 Oct 2025 07
- Akero Therapeutics Stock Surges on Novo Nordisk Buyout - Schaeffer's Investment Research hu, 09 Oct 2025 07
- M&A News: Akero Therapeutics Stock (AKRO) Zooms 19% after Novo Nordisk Buys it for $5.2B - TipRanks hu, 09 Oct 2025 07
- Akero Therapeutics Stock Surges 19% After Novo Nordisk’s $5.2B Acquisition Deal - Meyka hu, 09 Oct 2025 07
- Akero Therapeutics (AKRO) Jumps 16% on $5.2-Billion Novo Nordisk Merger - Yahoo Finance hu, 09 Oct 2025 07
- Akero Therapeutics, Inc. (AKRO) Stock Analysis: A Biotech Hopeful with a 4% Upside Potential - DirectorsTalk Interviews Mon, 20 Oct 2025 07
- Is AKRO stock undervalued right now - Trade Risk Assessment & AI Forecasted Entry/Exit Points - mfd.ru Wed, 18 Feb 2026 02
- Novo Nordisk's Akero Deal: Panic Buy Or Wise Decision? Here's My Take (NYSE:NVO) - Seeking Alpha hu, 09 Oct 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AKRO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|